Hints and tips:
Related Special Reports
...Curaleaf is listed on the Toronto Stock Exchange in Canada, which legalised consumption and limited production of cannabis in 2018....
...“Having a broken leg didn’t make me a lesser person, but it did dictate my immediate actions and greatly limited my options in the moment,” the 57-year-old said on Tuesday....
...The practice is currently limited to a small number of companies, including Illumina and Allelica, and its use is not yet widespread....
...The website also refers to an “Alba Developments” as the trading name for S Developments Limited, a company discussed by Burke and Wen in their WhatsApp messages as being the entity controlling Burke’s Scottish...
...This month Brazil started distributing a vaccine produced by Japanese pharmaceutical group Takeda....
...If treatment facilities are unavailable or unaffordable, the diagnosis may be of limited benefit — and may add to the psychological burden on patients....
...It already made its diagnostics products in the country but had “limited manufacturing for pharma”, he added....
...Aim biotech companies complain of liquidity constraints, high regulatory costs and limited access to funding....
...Developing new antibiotics is often unattractive for pharmaceutical companies, as research and development costs are high but their use is designed to be limited to reduce the risk of the product driving...
...His comments come as the Danish pharmaceutical company reported better than expected quarterly sales of DKr65bn ($9.3bn) on Thursday, up 24 per cent year on year at constant exchange rates....
...The company said the decision was partly driven by huge demand for weight-loss drugs....
...The Association of the British Pharmaceutical Industry, the drugmakers’ trade body, said it supported “this tough deal” even though the agreement would continue to restrict pharmaceutical companies’ sales...
...make up the backbone of pharmaceutical care....
...The pharmaceutical industry is close to agreeing a deal with the UK government over drug pricing, according to the chief financial officer of Swiss drugmaker Novartis....
...In the UK, Wegovy is available in limited supply on the NHS but patients using private healthcare can pay up to £300 for a month’s supply. Costs are similar in Denmark and Germany....
...This would involve pharmaceutical companies helping to fund the monitoring of new pathogens, which would in turn speed efforts at vaccine development....
...Until this year, the biggest obesity deal was worth up to $185mn, when Japan’s Takeda Pharmaceuticals sold the US rights to the weight loss drug Contrave to California-based Orexigen Therapeutics in 2016...
...Michael Lohan said Ireland was poised to win several big investments from pharmaceutical and medical device companies attracted to the country’s blend of tax incentives, political stability, skilled workforce...
...Companies: Vertex Pharmaceuticals and Tyson Foods report results before the market opens. Coty and Palantir will report after the close....
...“So it is particularly important to protect our limited [stock] of effective anti-fungal drugs.”...
...In contrast, pharmaceutical companies raised just $160mn for antibiotic research, a decline over the decade. Commercial activity and research in antibiotics have been in decline since the 1980s....
...Previously, the functionality of the engineered microbes was limited because their DNA could only be reprogrammed to produce a small number of amino acids — the building blocks of proteins....
...The current draft does not address this and is thus essentially limited to enabling the manufacture of comparatively simple pharmaceutical products, which generally do not require access to information that...
...Discovering this DNA signature of tumours requires whole genome sequencing — reading all 3.2bn letters of genetic code in their DNA — rather than carrying out a more limited panel of genetic tests, which...
...“As more big pharmaceutical companies show interest [in our work], we will make the AACR event an occasion to sign global partnerships.”...
International Edition